Crane Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crane Co. on January 29, 2018. The filing primarily serves to announce the Company's results of operations for the quarter ended December 31, 2017, and to provide detailed updates regarding its asbestos liability and related litigation activities. The specific financial results for the quarter are referenced in an attached press release (Exhibit 99.1) but are not detailed within the text of this filing.
Key Financial Metrics: Asbestos Liability and Costs
The filing provides extensive data regarding asbestos-related claims, costs, and liabilities, which represent a material contingent liability for the Company.
- Asbestos Liability Reserve: The total estimated liability for pending and future claims through 2059 was $605 million as of December 31, 2017, down from $696 million as of December 31, 2016.
- Current Portion: The current portion of the liability, representing costs expected to be paid within the next twelve months, was $85 million.
- Insurance Receivable: The estimated probable insurance reimbursement asset was $115 million as of December 31, 2017, down from $143 million in the prior year.
- Costs Incurred (2017): Total gross settlement and defense costs incurred were $88.3 million, comprising $51.8 million in settlement/indemnity costs and $36.5 million in defense costs.
- Cash Payments (2017): Total pre-tax cash payments, net of insurance receipts, were $62.5 million.
- Pending Claims: There were 32,234 pending claims as of December 31, 2017, a decrease from 36,052 in 2016.
Material Changes and Litigation Updates
The Company reported several significant developments in its asbestos litigation portfolio during the period:
- Liability Estimate Stability: Management determined that no change to the asbestos liability estimate was warranted for the period ended December 31, 2017, as actual experience approximated the assumptions made in the 2016 update.
- Claim Activity: New claims filed in 2017 were 2,819, while dismissals totaled 5,599 and settlements were 1,038.
- Key Verdicts and Settlements:
- James Nelson (PA): A $4.0 million verdict was vacated by the Supreme Court of Pennsylvania; a new trial is set for April 2018.
- Richard DeLisle (FL): A $1.3 million judgment was reversed in favor of the Company by the Florida Court of Appeals. The Florida Supreme Court granted review, with oral argument set for March 6, 2018.
- George Coulbourn (AZ): A $6.8 million judgment is under appeal to the Ninth Circuit, with oral argument set for March 15, 2018.
- James Poage (MO): A $10.8 million judgment was affirmed by the Missouri Court of Appeals. The Company is seeking review by the U.S. Supreme Court.
- Recent Settlements: The Company settled the Geoffrey Anisansel claim (August 2017) and the Valent Rabovsky claim (Q4 2017).
Outlook, Risks, and Contingencies
Management highlighted significant uncertainties regarding the ultimate exposure for asbestos-related claims. Key risk factors include:
- Estimation Variables: The liability estimate relies on assumptions regarding future claim volumes, settlement costs, dismissal rates, and defense costs, which are interdependent and subject to change.
- Legal and Legislative Factors: Changes in case law, legislative solutions, or significant adverse verdicts that withstand appeal could materially alter the liability estimate.
- Insurance Recovery: The estimated insurance reimbursement is subject to the financial viability of insurers, policy interpretation, and allocation methods. Actual reimbursements may vary from estimates.
- Forecast Period: The liability estimate covers claims projected through 2059. Cash payments are expected to continue for years beyond this date due to the lag between filing and resolution.
Investor Verification Checklist
- Verify the specific revenue, profit, and cash flow figures for the quarter ended December 31, 2017, in the attached Exhibit 99.1 (Earnings Press Release), as they are not detailed in this 8-K text.
- Monitor the outcomes of the pending Supreme Court and appellate court hearings scheduled for March 2018 (DeLisle, Coulbourn, Nelson), as these could impact future liability estimates.
- Review the trend of new mesothelioma claims versus dismissals to assess the stability of the $605 million liability reserve.
- Assess the financial health of the Company's excess insurers to validate the $115 million insurance receivable asset.
- Track the ratio of settlement costs to defense costs, noting that settlement costs ($51.8M) exceeded defense costs ($36.5M) in 2017.